COVID-19 Impact on Oncology (Anti-cancer Drugs) Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Oncology (Anti-cancer Drugs), including the following market information:
Major competitors identified in this market include Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co, Pfizer, Merck & Co., Sanofi, etc.
Based on the Region:
- Global Oncology (Anti-cancer Drugs) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Oncology (Anti-cancer Drugs) Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Oncology (Anti-cancer Drugs) Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Oncology (Anti-cancer Drugs) Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co, Pfizer, Merck & Co., Sanofi, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Others
- Chemotherapy
- Targeted Therapy
- Immunotherapy (Biologic Therapy)
- Hormonal Therapy
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Oncology (Anti-cancer Drugs) Industry
1.7 COVID-19 Impact: Oncology (Anti-cancer Drugs) Market Trends
2 GLOBAL ONCOLOGY (ANTI-CANCER DRUGS) QUARTERLY MARKET SIZE ANALYSIS
2.1 Oncology (Anti-cancer Drugs) Business Impact Assessment - COVID-19
2.1.1 Global Oncology (Anti-cancer Drugs) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Oncology (Anti-cancer Drugs) Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Oncology (Anti-cancer Drugs) Quarterly Market Size, 2019 VS 2020
3.2 By Players, Oncology (Anti-cancer Drugs) Headquarters and Area Served
3.3 Date of Key Players Enter into Oncology (Anti-cancer Drugs) Market
3.4 Key Players Oncology (Anti-cancer Drugs) Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON ONCOLOGY (ANTI-CANCER DRUGS) SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Blood Cancer
1.4.2 Breast Cancer
1.4.3 Gastrointestinal Cancer
1.4.4 Prostate Cancer
1.4.5 Others
4.2 By Type, Global Oncology (Anti-cancer Drugs) Market Size, 2019-2021
5 IMPACT OF COVID-19 ON ONCOLOGY (ANTI-CANCER DRUGS) SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Chemotherapy
5.5.2 Targeted Therapy
5.5.3 Immunotherapy (Biologic Therapy)
5.5.4 Hormonal Therapy
5.5.5 Others
5.2 By Application, Global Oncology (Anti-cancer Drugs) Market Size, 2019-2021
5.2.1 By Application, Global Oncology (Anti-cancer Drugs) Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Business Overview
7.1.2 Roche Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.1.3 Roche Oncology (Anti-cancer Drugs) Product Introduction
7.1.4 Roche Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.2.3 Novartis Oncology (Anti-cancer Drugs) Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Celgene
7.3.1 Celgene Business Overview
7.3.2 Celgene Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.3.3 Celgene Oncology (Anti-cancer Drugs) Product Introduction
7.3.4 Celgene Response to COVID-19 and Related Developments
7.4 Amgen
7.4.1 Amgen Business Overview
7.4.2 Amgen Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.4.3 Amgen Oncology (Anti-cancer Drugs) Product Introduction
7.4.4 Amgen Response to COVID-19 and Related Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Business Overview
7.5.2 Johnson & Johnson Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Product Introduction
7.5.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Business Overview
7.6.2 GlaxoSmithKline Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Introduction
7.6.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.7 Eli lilly & Co
7.7.1 Eli lilly & Co Business Overview
7.7.2 Eli lilly & Co Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Product Introduction
7.7.4 Eli lilly & Co Response to COVID-19 and Related Developments
7.8 Pfizer
7.8.1 Pfizer Business Overview
7.8.2 Pfizer Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.8.3 Pfizer Oncology (Anti-cancer Drugs) Product Introduction
7.8.4 Pfizer Response to COVID-19 and Related Developments
7.9 Merck & Co.
7.9.1 Merck & Co. Business Overview
7.9.2 Merck & Co. Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Product Introduction
7.9.4 Merck & Co. Response to COVID-19 and Related Developments
7.10 Sanofi
7.10.1 Sanofi Business Overview
7.10.2 Sanofi Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.10.3 Sanofi Oncology (Anti-cancer Drugs) Product Introduction
7.10.4 Sanofi Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Oncology (Anti-cancer Drugs) Industry
1.7 COVID-19 Impact: Oncology (Anti-cancer Drugs) Market Trends
2 GLOBAL ONCOLOGY (ANTI-CANCER DRUGS) QUARTERLY MARKET SIZE ANALYSIS
2.1 Oncology (Anti-cancer Drugs) Business Impact Assessment - COVID-19
2.1.1 Global Oncology (Anti-cancer Drugs) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Oncology (Anti-cancer Drugs) Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Oncology (Anti-cancer Drugs) Quarterly Market Size, 2019 VS 2020
3.2 By Players, Oncology (Anti-cancer Drugs) Headquarters and Area Served
3.3 Date of Key Players Enter into Oncology (Anti-cancer Drugs) Market
3.4 Key Players Oncology (Anti-cancer Drugs) Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON ONCOLOGY (ANTI-CANCER DRUGS) SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Blood Cancer
1.4.2 Breast Cancer
1.4.3 Gastrointestinal Cancer
1.4.4 Prostate Cancer
1.4.5 Others
4.2 By Type, Global Oncology (Anti-cancer Drugs) Market Size, 2019-2021
5 IMPACT OF COVID-19 ON ONCOLOGY (ANTI-CANCER DRUGS) SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Chemotherapy
5.5.2 Targeted Therapy
5.5.3 Immunotherapy (Biologic Therapy)
5.5.4 Hormonal Therapy
5.5.5 Others
5.2 By Application, Global Oncology (Anti-cancer Drugs) Market Size, 2019-2021
5.2.1 By Application, Global Oncology (Anti-cancer Drugs) Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Business Overview
7.1.2 Roche Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.1.3 Roche Oncology (Anti-cancer Drugs) Product Introduction
7.1.4 Roche Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.2.3 Novartis Oncology (Anti-cancer Drugs) Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Celgene
7.3.1 Celgene Business Overview
7.3.2 Celgene Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.3.3 Celgene Oncology (Anti-cancer Drugs) Product Introduction
7.3.4 Celgene Response to COVID-19 and Related Developments
7.4 Amgen
7.4.1 Amgen Business Overview
7.4.2 Amgen Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.4.3 Amgen Oncology (Anti-cancer Drugs) Product Introduction
7.4.4 Amgen Response to COVID-19 and Related Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Business Overview
7.5.2 Johnson & Johnson Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Product Introduction
7.5.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Business Overview
7.6.2 GlaxoSmithKline Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Introduction
7.6.4 GlaxoSmithKline Response to COVID-19 and Related Developments
7.7 Eli lilly & Co
7.7.1 Eli lilly & Co Business Overview
7.7.2 Eli lilly & Co Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Product Introduction
7.7.4 Eli lilly & Co Response to COVID-19 and Related Developments
7.8 Pfizer
7.8.1 Pfizer Business Overview
7.8.2 Pfizer Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.8.3 Pfizer Oncology (Anti-cancer Drugs) Product Introduction
7.8.4 Pfizer Response to COVID-19 and Related Developments
7.9 Merck & Co.
7.9.1 Merck & Co. Business Overview
7.9.2 Merck & Co. Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Product Introduction
7.9.4 Merck & Co. Response to COVID-19 and Related Developments
7.10 Sanofi
7.10.1 Sanofi Business Overview
7.10.2 Sanofi Oncology (Anti-cancer Drugs) Quarterly Revenue, 2020
7.10.3 Sanofi Oncology (Anti-cancer Drugs) Product Introduction
7.10.4 Sanofi Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Oncology (Anti-cancer Drugs) Assessment
Table 9. COVID-19 Impact: Oncology (Anti-cancer Drugs) Market Trends
Table 10. COVID-19 Impact Global Oncology (Anti-cancer Drugs) Market Size
Table 11. Global Oncology (Anti-cancer Drugs) Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Oncology (Anti-cancer Drugs) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Oncology (Anti-cancer Drugs) Market Growth Drivers
Table 14. Global Oncology (Anti-cancer Drugs) Market Restraints
Table 15. Global Oncology (Anti-cancer Drugs) Market Opportunities
Table 16. Global Oncology (Anti-cancer Drugs) Market Challenges
Table 17. By Players, Oncology (Anti-cancer Drugs) Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Oncology (Anti-cancer Drugs) Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Oncology (Anti-cancer Drugs) Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Oncology (Anti-cancer Drugs) Market
Table 21. Key Players Oncology (Anti-cancer Drugs) Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Oncology (Anti-cancer Drugs) Market Size 2019-2021, (US$ Million)
Table 24. Global Oncology (Anti-cancer Drugs) Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Oncology (Anti-cancer Drugs) Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 57. Roche Business Overview
Table 58. Roche Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Roche Oncology (Anti-cancer Drugs) Product
Table 60. Roche Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis Oncology (Anti-cancer Drugs) Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Celgene Business Overview
Table 66. Celgene Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Celgene Oncology (Anti-cancer Drugs) Product
Table 68. Celgene Response to COVID-19 and Related Developments
Table 69. Amgen Business Overview
Table 70. Amgen Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Amgen Oncology (Anti-cancer Drugs) Product
Table 72. Amgen Response to COVID-19 and Related Developments
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Johnson & Johnson Oncology (Anti-cancer Drugs) Product
Table 76. Johnson & Johnson Response to COVID-19 and Related Developments
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product
Table 80. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 81. Eli lilly & Co Business Overview
Table 82. Eli lilly & Co Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Eli lilly & Co Oncology (Anti-cancer Drugs) Product
Table 84. Eli lilly & Co Response to COVID-19 and Related Developments
Table 85. Pfizer Business Overview
Table 86. Pfizer Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pfizer Oncology (Anti-cancer Drugs) Product
Table 88. Pfizer Response to COVID-19 and Related Developments
Table 89. Merck & Co. Business Overview
Table 90. Merck & Co. Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Merck & Co. Oncology (Anti-cancer Drugs) Product
Table 92. Merck & Co. Response to COVID-19 and Related Developments
Table 93. Sanofi Business Overview
Table 94. Sanofi Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sanofi Oncology (Anti-cancer Drugs) Product
Table 96. Sanofi Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Oncology (Anti-cancer Drugs) Assessment
Table 9. COVID-19 Impact: Oncology (Anti-cancer Drugs) Market Trends
Table 10. COVID-19 Impact Global Oncology (Anti-cancer Drugs) Market Size
Table 11. Global Oncology (Anti-cancer Drugs) Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Oncology (Anti-cancer Drugs) Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Oncology (Anti-cancer Drugs) Market Growth Drivers
Table 14. Global Oncology (Anti-cancer Drugs) Market Restraints
Table 15. Global Oncology (Anti-cancer Drugs) Market Opportunities
Table 16. Global Oncology (Anti-cancer Drugs) Market Challenges
Table 17. By Players, Oncology (Anti-cancer Drugs) Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Oncology (Anti-cancer Drugs) Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Oncology (Anti-cancer Drugs) Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Oncology (Anti-cancer Drugs) Market
Table 21. Key Players Oncology (Anti-cancer Drugs) Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Oncology (Anti-cancer Drugs) Market Size 2019-2021, (US$ Million)
Table 24. Global Oncology (Anti-cancer Drugs) Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Oncology (Anti-cancer Drugs) Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Oncology (Anti-cancer Drugs) Market Size, 2019-2021 (US$ Million)
Table 57. Roche Business Overview
Table 58. Roche Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Roche Oncology (Anti-cancer Drugs) Product
Table 60. Roche Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis Oncology (Anti-cancer Drugs) Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Celgene Business Overview
Table 66. Celgene Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Celgene Oncology (Anti-cancer Drugs) Product
Table 68. Celgene Response to COVID-19 and Related Developments
Table 69. Amgen Business Overview
Table 70. Amgen Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Amgen Oncology (Anti-cancer Drugs) Product
Table 72. Amgen Response to COVID-19 and Related Developments
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Johnson & Johnson Oncology (Anti-cancer Drugs) Product
Table 76. Johnson & Johnson Response to COVID-19 and Related Developments
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product
Table 80. GlaxoSmithKline Response to COVID-19 and Related Developments
Table 81. Eli lilly & Co Business Overview
Table 82. Eli lilly & Co Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Eli lilly & Co Oncology (Anti-cancer Drugs) Product
Table 84. Eli lilly & Co Response to COVID-19 and Related Developments
Table 85. Pfizer Business Overview
Table 86. Pfizer Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pfizer Oncology (Anti-cancer Drugs) Product
Table 88. Pfizer Response to COVID-19 and Related Developments
Table 89. Merck & Co. Business Overview
Table 90. Merck & Co. Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Merck & Co. Oncology (Anti-cancer Drugs) Product
Table 92. Merck & Co. Response to COVID-19 and Related Developments
Table 93. Sanofi Business Overview
Table 94. Sanofi Oncology (Anti-cancer Drugs) Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Sanofi Oncology (Anti-cancer Drugs) Product
Table 96. Sanofi Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Oncology (Anti-cancer Drugs) Product Picture
Figure 2. Oncology (Anti-cancer Drugs) Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Oncology (Anti-cancer Drugs) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Oncology (Anti-cancer Drugs) Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Oncology (Anti-cancer Drugs) Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Oncology (Anti-cancer Drugs) Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Oncology (Anti-cancer Drugs) Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Oncology (Anti-cancer Drugs) Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Oncology (Anti-cancer Drugs) Market Size Market Share, 2019-2021
Figure 1. Oncology (Anti-cancer Drugs) Product Picture
Figure 2. Oncology (Anti-cancer Drugs) Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Oncology (Anti-cancer Drugs) Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Oncology (Anti-cancer Drugs) Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Oncology (Anti-cancer Drugs) Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Oncology (Anti-cancer Drugs) Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Oncology (Anti-cancer Drugs) Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Oncology (Anti-cancer Drugs) Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Oncology (Anti-cancer Drugs) Market Size Market Share, 2019-2021
